Leta i den här bloggen

torsdag 16 december 2021

Virus G-quadruplex terapian kohteeksi , myös Sars-2 koronaviruksessa?

 https://www.mdpi.com/1422-0067/22/20/10984/htm

 

 

Review

G-Quadruplex Targeting in the Fight against Viruses: An Update

Department of Molecular Medicine, University of Padua, 35121 Padua, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Alessandro Di Minno
Int. J. Mol. Sci. 2021, 22(20), 10984; https://doi.org/10.3390/ijms222010984
Received: 20 September 2021 / Revised: 7 October 2021 / Accepted: 8 October 2021 / Published: 12 October 2021

Abstract

G-quadruplexes (G4s) are noncanonical nucleic acid structures involved in the regulation of key cellular processes, such as transcription and replication. Since their discovery, G4s have been mainly investigated for their role in cancer and as targets in anticancer therapy. More recently, exploration of the presence and role of G4s in viral genomes has led to the discovery of G4-regulated key viral pathways. In this context, employment of selective G4 ligands has helped to understand the complexity of G4-mediated mechanisms in the viral life cycle, and highlighted the possibility to target viral G4s as an emerging antiviral approach. Research in this field is growing at a fast pace, providing increasing evidence of the antiviral activity of old and new G4 ligands. This review aims to provide a punctual update on the literature on G4 ligands exploited in virology. Different classes of G4 binders are described, with emphasis on possible antiviral applications in emerging diseases, such as the current COVID-19 pandemic. Strengths and weaknesses of G4 targeting in viruses are discussed. View Full-Text
Show Figures

Figure 1

Inga kommentarer:

Skicka en kommentar